NKTX
Price
$1.68
Change
-$0.06 (-3.47%)
Updated
Jun 27 closing price
Capitalization
118.85M
39 days until earnings call
RGLS
Price
$8.16
Change
+$0.02 (+0.25%)
Updated
Jun 24 closing price
Capitalization
564.95M
44 days until earnings call
Interact to see
Advertisement

NKTX vs RGLS

Header iconNKTX vs RGLS Comparison
Open Charts NKTX vs RGLSBanner chart's image
Nkarta
Price$1.68
Change-$0.06 (-3.47%)
Volume$625.36K
Capitalization118.85M
Regulus Therapeutics
Price$8.16
Change+$0.02 (+0.25%)
Volume$9.34M
Capitalization564.95M
NKTX vs RGLS Comparison Chart in %
Loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTX vs. RGLS commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTX is a Hold and RGLS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (NKTX: $1.67 vs. RGLS: $8.16)
Brand notoriety: NKTX and RGLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTX: 130% vs. RGLS: 300%
Market capitalization -- NKTX: $118.85M vs. RGLS: $564.95M
NKTX [@Biotechnology] is valued at $118.85M. RGLS’s [@Biotechnology] market capitalization is $564.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTX’s FA Score shows that 1 FA rating(s) are green whileRGLS’s FA Score has 0 green FA rating(s).

  • NKTX’s FA Score: 1 green, 4 red.
  • RGLS’s FA Score: 0 green, 5 red.
According to our system of comparison, RGLS is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTX’s TA Score shows that 2 TA indicator(s) are bullish while RGLS’s TA Score has 3 bullish TA indicator(s).

  • NKTX’s TA Score: 2 bullish, 6 bearish.
  • RGLS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RGLS is a better buy in the short-term than NKTX.

Price Growth

NKTX (@Biotechnology) experienced а -5.37% price change this week, while RGLS (@Biotechnology) price change was +3.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

NKTX is expected to report earnings on Aug 07, 2025.

RGLS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGLS($565M) has a higher market cap than NKTX($119M). RGLS YTD gains are higher at: 416.456 vs. NKTX (-32.731). RGLS has higher annual earnings (EBITDA): -47.08M vs. NKTX (-122.8M). NKTX has more cash in the bank: 266M vs. RGLS (65.4M). RGLS has less debt than NKTX: RGLS (1.4M) vs NKTX (78.9M). NKTX (0) and RGLS (0) have equivalent revenues.
NKTXRGLSNKTX / RGLS
Capitalization119M565M21%
EBITDA-122.8M-47.08M261%
Gain YTD-32.731416.456-8%
P/E RatioN/AN/A-
Revenue00-
Total Cash266M65.4M407%
Total Debt78.9M1.4M5,632%
FUNDAMENTALS RATINGS
RGLS: Fundamental Ratings
RGLS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTXRGLS
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFCWX18.170.18
+1.00%
American Century Focused Intl Gr R
BMDSX20.590.13
+0.64%
Baird Mid Cap Growth Investor
FSPHX25.640.10
+0.39%
Fidelity Select Health Care
MSHNX14.94N/A
N/A
Morgan Stanley Inst Permanence A
GRHAX15.03-0.23
-1.51%
Goehring & Rozencwajg Resources Retail

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with CRBU. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-3.18%
CRBU - NKTX
51%
Loosely correlated
-5.19%
BEAM - NKTX
49%
Loosely correlated
-1.98%
FATE - NKTX
48%
Loosely correlated
-5.45%
IPSC - NKTX
47%
Loosely correlated
-5.74%
TERN - NKTX
46%
Loosely correlated
-4.25%
More

RGLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGLS has been loosely correlated with ABEO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RGLS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGLS
1D Price
Change %
RGLS100%
N/A
ABEO - RGLS
44%
Loosely correlated
-2.54%
ATOS - RGLS
33%
Poorly correlated
+1.64%
NAUT - RGLS
31%
Poorly correlated
-12.57%
NKTX - RGLS
31%
Poorly correlated
-3.18%
XENE - RGLS
30%
Poorly correlated
+0.62%
More